76 results
424B3
PRTG
Portage Biotech Inc
6 Mar 24
Prospectus supplement
9:36pm
capital investment Five potential phase 1b/2 clinical data reads over next 2 years* Engine for Efficient Drug Development & Commercialization Expert … pharma and biotech Packaged for commercialization/acquisition Expert Leadership with Track Record of Success Proven success, more than 10 oncology
6-K
EX-99.1
PRTG
Portage Biotech Inc
6 Mar 24
Current report (foreign)
9:11pm
reads over next 2 years* Engine for Efficient Drug Development & Commercialization Expert scientific oversight Lean structure with financial flexibility … /acquisition Expert Leadership with Track Record of Success Proven success, more than 10 oncology approvals Formation of Biohaven Pharmaceuticals, sale
424B3
PRTG
Portage Biotech Inc
18 Jan 24
Prospectus supplement
5:41pm
Development & Commercialization Expert scientific oversight Lean structure with financial flexibility Preferred Partner for Pharma in I/O Deep industry network … facilitates engagement with big pharma and biotech Packaged for commercialization/acquisition Expert Leadership with Track Record of Success Proven
6-K
EX-99.1
PRTG
Portage Biotech Inc
18 Jan 24
Current report (foreign)
5:09pm
clinical data reads over next 2 years* Engine for Efficient Drug Development & Commercialization Expert scientific oversight Lean structure … for commercialization/acquisition Expert Leadership with Track Record of Success Proven success, more than 10 oncology approvals Formation of Biohaven Pharmaceuticals
424B3
PRTG
Portage Biotech Inc
14 Nov 23
Prospectus supplement
6:00am
potential phase 1b/2 clinical data reads over next 2 years* Engine for Efficient Drug Development & Commercialization Expert scientific oversight Lean … for commercialization/acquisition Expert Leadership with Track Record of Success Proven success, more than 10 oncology approvals Formation
6-K
EX-99.1
st9qztjemi7f3gl
13 Nov 23
Current report (foreign)
6:10am
6-K
EX-5.2
ria igggy
3 Oct 23
Current report (foreign)
4:05pm
6-K
EX-99.1
z80ad
8 Sep 23
Current report (foreign)
4:01pm
6-K
EX-99.1
6poy7t8359ch9d4z nx8
14 Aug 23
Current report (foreign)
4:52pm
6-K
EX-99.1
no2in
20 Jun 23
Current report (foreign)
5:53pm
6-K
EX-99.1
39i7s9tdk9 r1
1 May 23
Current report (foreign)
8:00am
6-K
EX-99.1
l0c wr6lt55v76l
30 Nov 22
Current report (foreign)
9:08pm
6-K
EX-99.1
inbacpdvujkntz
14 Sep 22
Current report (foreign)
10:31am
6-K
EX-99.2
2aot90 am8
7 Jul 22
Portage Biotech Bolsters Pipeline with Acquisition of Four Candidates Targeting the Adenosine Pathway
8:30am